Medical Device News Magazine

Varian Acquires Aspekt Solutions, Strengthening Advanced Oncology Solutions Offering

Acquisition of Aspekt Solutions expands Varian's medical physics and dosimetry services, building on Varian's commitment to providing a holistic approach to cancer care.

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Varian, a Siemens Healthineers company, announced today that it has acquired Aspekt Solutions, a leading provider of medical physics, dosimetry, and strategy consultation services. The acquisition of Aspekt Solutions will expand Varian’s Advanced Oncology Solutions (AOS) offerings and increase the ability to address the rising demand for customized services and standardized care delivery.

Cancer care is evolving rapidly, and providers face numerous challenges, including the rising cost of care, technological complexity, and a shortage of skilled personnel. While navigating these challenges, cancer centers strive to meet several competing objectives in clinical quality, operational efficiency, and technology utilization. Through AOS, Varian offers tailored engagements that harness the power of technology and combine it with professional support from world-class experts with diverse clinical and operational experience. These teams collaborate with cancer centers to help them realize their unique goals for expanding, upgrading, or standardizing operations while implementing global best practices in cancer care.

“Through our AOS offerings, we’ve been leading the way in melding innovative technology with clinical expertise to help address these challenges,” commented Chuck Lindley, Vice President of AOS, at Varian. “With Aspekt Solutions, we can support more oncology centers with a holistic approach to addressing today’s challenges while also preparing for the fast-evolving future of cancer care.”

“As part of Varian, we are confident that we will have more opportunities to empower clinicians and patients around the world,” added Brian Pellegrini, CEO of Aspekt Solutions. “We are excited to continue our mission of bringing together the best team of physicists, dosimetrists, and consultants in the industry and partnering with clients to support and extend their existing programs and prepare them for the future. Our immediate focus will be on ensuring that the transition is as smooth as it is beneficial for customers and Aspekt Solutions employees.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”